Collectively, our findings indicate that WCC and ECC suppress PD-L1 expression on cancer cells, thereby reducing PD-L1/PD-1 immune checkpoint-mediated immune suppression, which in turn enhances T cell-mediated cytotoxicity against cancer. This evidence concerns the gene PDCD1 and cancer.